MODULATION OF INVITRO-CELL GROWTH OF HUMAN AND MURINE UROTHELIAL TUMOR-CELL LINES UNDER THE INFLUENCE OF INTERLEUKIN-3, GRANULOCYTE-COLONY-STIMULATING, MACROPHAGE-COLONY-STIMULATING AND GRANULOCYTE-COLONY-STIMULATING FACTOR

被引:16
作者
BLOCK, T [1 ]
SCHMID, F [1 ]
GEFFKEN, B [1 ]
TREIBER, U [1 ]
BUSCH, R [1 ]
HARTUNG, R [1 ]
机构
[1] TECH UNIV MUNICH,INST STAT & EPIDEMIOL,W-8000 MUNICH 80,GERMANY
来源
UROLOGICAL RESEARCH | 1992年 / 20卷 / 04期
关键词
INTERLEUKIN-3; GRANULOCYTE-MACROPHAGE-COLONY-STIMULATING FACTOR; GRANULOCYTE-COLONY-STIMULATING FACTOR; HUMAN TRANSITIONAL CELL CARCINOMA LINES; INVITRO GROWTH MODULATION;
D O I
10.1007/BF00300261
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To elucidate possible growth-modulating effects of interleukin 3 (IL-3), granulocyte-macrophage-colony-stimulating factor (GM-CSF) and granulocyte-colony-stimulating factor (G-CSF), human transitional cell carcinoma (TCC) cell lines T24, RT112, EJ and 647V were solitarily and continuously exposed to these hematopoietic growth factors at concentrations of 1-100 ng/ml. The murine line MBT-2 was used as a negative and the colon carcinoma cell line HTB38 as a positive control, because of species specificity and known proliferation in response to growth factors, respectively. In the T24 TCC-line solitary and continuous exposure to IL-3, GM-CSF and G-CSF at the highest concentration of 100 ng/ml led to a significant proliferation of cell growth in vitro. Significant proliferation in the RT112 line was only achieved with continuous exposure to IL-3 and GM-CSF (100 ng/ml); G-CSF failed to induce growth modulation in the RT112 line. No significant proliferative effect of any of cytokines administered was observed in the 647V line. Exposure of the EJ line to cytokines at the highest activity levels had a proliferative effect only in suboptimal growth conditions.
引用
收藏
页码:289 / 292
页数:4
相关论文
共 13 条
[1]  
BALDWIN GC, 1989, BLOOD, V73, P1033
[2]  
BERDEL WE, 1989, BLOOD, V73, P80
[3]  
BERDEL WE, 1991, ANN HEMATOL, V62, pA4
[4]   HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR IS A GROWTH-FACTOR ACTIVE ON A VARIETY OF CELL-TYPES OF NONHEMOPOIETIC ORIGIN [J].
DEDHAR, S ;
GABOURY, L ;
GALLOWAY, P ;
EAVES, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) :9253-9257
[5]   EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR ON NEUTROPENIA AND ASSOCIATED MORBIDITY DUE TO CHEMOTHERAPY FOR TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM [J].
GABRILOVE, JL ;
JAKUBOWSKI, A ;
SCHER, H ;
STERNBERG, C ;
WONG, G ;
GROUS, J ;
YAGODA, A ;
FAIN, K ;
MOORE, MAS ;
CLARKSON, B ;
OETTGEN, HF ;
ALTON, K ;
WELTE, K ;
SOUZA, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (22) :1414-1422
[6]  
GRIFFIN JD, 1991, ANN HEMATOL, V62, pA11
[7]  
HERRMANN F, 1991, ANN HEMATOL, V62, P123
[8]  
HILL BT, 1991, EUR J CANCER, V27, P231
[9]   ESCALATED THERAPY FOR REFRACTORY UROTHELIAL TUMORS - METHOTREXATE-VINBLASTINE-DOXORUBICIN-CISPLATIN PLUS UNGLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [J].
LOGOTHETIS, CJ ;
DEXEUS, FH ;
SELLA, A ;
AMATO, RJ ;
KILBOURN, RG ;
FINN, L ;
GUTTERMAN, JU .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (08) :667-672
[10]  
OHIGASHI T, 1990, Keio Journal of Medicine, V39, P254